Today: 14 May 2026
Browse Category

LSE:RPI.L 18 February 2026 - 19 February 2026

Raspberry Pi shares surge on OpenClaw AI agent buzz as CEO Eben Upton buying draws retail traders

Raspberry Pi shares surge on OpenClaw AI agent buzz as CEO Eben Upton buying draws retail traders

Raspberry Pi shares surged 42% on Tuesday after CEO Eben Upton bought stock and traders bet on AI tools like OpenClaw running on its low-cost boards. The stock closed up 36% at 415 pence, lifting the company’s market value to about £1 billion. Investors cited growing interest in “local AI” on cheap devices instead of cloud servers. Raspberry Pi shipped 7.6 million units in 2025, but warned of risks from rising memory costs.
19 February 2026
··
Raspberry Pi share price jumps again as CEO buy and AI chatter keep RPI.L in play

Raspberry Pi share price jumps again as CEO buy and AI chatter keep RPI.L in play

Raspberry Pi Holdings shares surged 25.2% to 519.5 pence in early London trading, after CEO Eben Upton disclosed buying 4,684 shares for about £13,224. The rally follows heavy social-media speculation on the company’s role in low-cost AI projects. Two traders said the driver was unclear. The company stated there was no new information beyond public disclosures.
18 February 2026
···

Stock Market Today

  • Nanjing Leads Biolabs (SEHK:9887) Faces Valuation Challenges Amid Share Price Volatility
    May 14, 2026, 2:53 AM EDT. Nanjing Leads Biolabs, a clinical-stage biotech focused on antibody drugs, saw its shares drop 8% in one day and 12% over the past week despite a strong 3-month and year-to-date rally. The stock closed at HK$69.40, valuing the company at roughly HK$13.8 billion. Recent declines reflect investor caution over growth prospects and clinical pipeline risks. The discounted cash flow (DCF) model estimates an intrinsic value of HK$18.62 per share, far below current prices, suggesting the stock is trading at a steep premium. As the company posts revenue growth but still reports a net loss of CN¥211.419 million, further volatility is likely. Investors should watch pipeline progress closely, given the risk that elevated losses and delayed commercialization could trigger a correction.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 14.05.2026

14 May 2026
LIVEMarkets rolling coverageStarted: May 14, 2026, 12:00 AM EDTUpdated: May 14, 2026, 2:53 AM EDT Nanjing Leads Biolabs (SEHK:9887) Faces Valuation Challenges Amid Share Price Volatility May 14, 2026, 2:53 AM EDT. Nanjing Leads Biolabs, a clinical-stage biotech focused on antibody drugs, saw its shares drop **8% in one day** and **12% over the past week** despite a strong 3-month and year-to-date rally. The stock closed at HK$69.40, valuing the company at roughly HK$13.8 billion. Recent declines reflect investor caution over growth prospects and clinical pipeline risks. The **discounted cash flow (DCF) model** estimates an intrinsic value of HK$18.62 per
Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
Go toTop